Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 70.61% | -25.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.14% | -23.11% | |||
| Operating Income | -10.14% | 23.11% | |||
| Income Before Tax | -3.92% | 49.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.96% | 49.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.96% | 49.55% | |||
| EBIT | -10.14% | 23.11% | |||
| EBITDA | -10.20% | 23.17% | |||
| EPS Basic | 52.55% | 59.10% | |||
| Normalized Basic EPS | -8.34% | 36.79% | |||
| EPS Diluted | 52.55% | 59.10% | |||
| Normalized Diluted EPS | -8.34% | 36.79% | |||
| Average Basic Shares Outstanding | 1.23% | 23.36% | |||
| Average Diluted Shares Outstanding | 1.23% | 23.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||